These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 15365217

  • 1. Neuronal dysfunction of the frontal lobe in schizophrenia.
    Pae CU, Choe BY, Joo RH, Lim HK, Kim TS, Yoo SS, Choi BG, Kim JJ, Lee SJ, Lee C, Paik IH, Lee CU.
    Neuropsychobiology; 2004; 50(3):211-5. PubMed ID: 15365217
    [Abstract] [Full Text] [Related]

  • 2. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P, Siegmund A, Suslow T, Pedersen A, Spitzberg K, Kersting A, Rothermundt M, Arolt V, Heindel W, Pfleiderer B.
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [Abstract] [Full Text] [Related]

  • 3. [Clinical and neuropsychological correlates of proton magnetic resonance spectroscopy detected metabolites in brains of first-episode and schizophrenic patients].
    Szulc A, Galińska B, Tarasów E, Walecki J, Dzienis W, Kubas B, Czernikiewicz A.
    Psychiatr Pol; 2003 Oct; 37(6):977-88. PubMed ID: 14727370
    [Abstract] [Full Text] [Related]

  • 4. Proton magnetic resonance spectroscopy study of brain metabolite changes after antipsychotic treatment.
    Szulc A, Galinska B, Tarasow E, Waszkiewicz N, Konarzewska B, Poplawska R, Bibulowicz D, Simonienko K, Walecki J.
    Pharmacopsychiatry; 2011 Jun; 44(4):148-57. PubMed ID: 21710405
    [Abstract] [Full Text] [Related]

  • 5. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
    Tanaka Y, Obata T, Sassa T, Yoshitome E, Asai Y, Ikehira H, Suhara T, Okubo Y, Nishikawa T.
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755
    [Abstract] [Full Text] [Related]

  • 6. The effect of risperidone on metabolite measures in the frontal lobe, temporal lobe, and thalamus in schizophrenic patients. A proton magnetic resonance spectroscopy (1H MRS).
    Szulc A, Galinska B, Tarasow E, Dzienis W, Kubas B, Konarzewska B, Walecki J, Alathiaki AS, Czernikiewicz A.
    Pharmacopsychiatry; 2005 Sep; 38(5):214-9. PubMed ID: 16189748
    [Abstract] [Full Text] [Related]

  • 7. [Proton magnetic resonance spectroscopy of prefrontal lobe and thalamus in schizophrenics: correlation with clinical characteristics].
    Gan JL, Duan HF, Yang JM, Shi ZJ, Zhang DW, Jiang ZK, Gao CY, Wang ZJ.
    Zhonghua Yi Xue Za Zhi; 2011 Nov 22; 91(43):3034-9. PubMed ID: 22333054
    [Abstract] [Full Text] [Related]

  • 8. Proton magnetic resonance spectroscopy measures related to short-term symptomatic outcome in chronic schizophrenia.
    Szulc A, Konarzewska B, Galinska-Skok B, Lazarczyk J, Waszkiewicz N, Tarasow E, Milewski R, Walecki J.
    Neurosci Lett; 2013 Jun 28; 547():37-41. PubMed ID: 23665527
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic naive patients with schizophrenia.
    Cecil KM, Lenkinski RE, Gur RE, Gur RC.
    Neuropsychopharmacology; 1999 Feb 28; 20(2):131-40. PubMed ID: 9885793
    [Abstract] [Full Text] [Related]

  • 11. Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy.
    Deicken RF, Zhou L, Schuff N, Fein G, Weiner MW.
    Biol Psychiatry; 1998 Apr 01; 43(7):483-8. PubMed ID: 9547926
    [Abstract] [Full Text] [Related]

  • 12. Relationship between frontal N-acetylaspartate and cognitive deficits in first-episode schizophrenia.
    Galińska B, Szulc A, Tarasów E, Kubas B, Dzienis W, Siergiejczyk L, Czernikiewicz A, Walecki J.
    Med Sci Monit; 2007 May 01; 13 Suppl 1():11-6. PubMed ID: 17507879
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.
    Jessen F, Scherk H, Träber F, Theyson S, Berning J, Tepest R, Falkai P, Schild HH, Maier W, Wagner M, Block W.
    Schizophr Res; 2006 Oct 01; 87(1-3):81-8. PubMed ID: 16842971
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Are personality traits of juvenile myoclonic epilepsy related to frontal lobe dysfunctions? A proton MRS study.
    de Araújo Filho GM, Lin K, Lin J, Peruchi MM, Caboclo LO, Guaranha MS, Guilhoto LM, Carrete H, Yacubian EM.
    Epilepsia; 2009 May 01; 50(5):1201-9. PubMed ID: 19400877
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Proton magnetic resonance spectroscopy of the inferior frontal gyrus and thalamus and its relationship to verbal learning task performance in patients with schizophrenia: a preliminary report.
    Hagino H, Suzuki M, Mori K, Nohara S, Yamashita I, Takahashi T, Kurokawa K, Matsui M, Watanabe N, Seto H, Kurachi M.
    Psychiatry Clin Neurosci; 2002 Oct 01; 56(5):499-507. PubMed ID: 12193238
    [Abstract] [Full Text] [Related]

  • 19. A proton magnetic resonance spectroscopic study in juvenile absence epilepsy in early stages.
    Kabay SC, Gumustas OG, Karaman HO, Ozden H, Erdinc O.
    Eur J Paediatr Neurol; 2010 May 01; 14(3):224-8. PubMed ID: 19616977
    [Abstract] [Full Text] [Related]

  • 20. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J, Levitt J, Caplan R, Asarnow R, McCracken JT, Toga AW, Alger JR.
    Neuroimage; 2004 Apr 01; 21(4):1781-9. PubMed ID: 15050598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.